Researchers at the National Safety Council and the University of Michigan found that about one in 20 adolescents ages 10 to 17 and one in 10 young adults ages 18 to 25 report prescription opioid misuse, based on a new review published in Preventive Medicine. However, effective intervention programs are not in place to address prescription opioid misuse among young people, and NSC and University of Michigan Injury Prevention Center researchers are urgently calling for evidence-based prevention programs to be developed and tested.

A national survey conducted by the U.S. Pain Foundation, with support from McNeil Consumer Healthcare, has found that while nearly all consumers (97%) say they feel confident when choosing which over-the-counter (OTC) pain reliever to take, many disregard important safety factors that medical professionals say are critical to selecting which OTC pain reliever is most appropriate for their health profile.

Drug overdose is the leading cause of injury death in the United States – mostly due to abuse and misuse of prescription opioid pain relievers, benzodiazepines (sedatives/tranquilizers), and stimulants. Information from state prescription drug monitoring programs (PDMPs) can be used to detect and measure prescribing patterns that suggest abuse and misuse of controlled substances, according to a report released today in the Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality Weekly Report (MMWR) Surveillance Summary.